Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Vattenfall to present interim report for January-March 2023 on April 27

Vattenfall's interim report for January to March 2023 will be published on Wednesday April 27 at 08.00 CEST on group.vattenfall.com. A live broadcast for analysts and media will start at 09.30 CEST.Vattenfall’s President and CEO Anna Borg and CFO Kerstin Ahlfont will present the results together with Senior Vice President Strategic Development Andreas Regnell. The presentation and following Q&A session will be held in English. Link: Vattenfall Q1 2023 

Invitation to presentation of SBB’s interim report January-March 2023

Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) will publish its interim report for January-March 2023 on 28 April 2023 at 08:00 CEST. SBB’s CEO Ilija Batljan will present the results on the same day at 10:00 CEST via conference call and webcast. The presentation will be held in English and will be concluded with a Q&A session. Questions can be asked on the conference call or in written form through the webcast. The report will be available at: https://corporate.sbbnorden.se/en/reports-and-presentations/ If you wish to participate via webcast, please use the link below. Via the

Invitation to Medicover’s results presentation for Q1 2023

Medicover’s (MCOV B) Q1 report 2023 will be published on 27 April at 07.45 CEST. The Company will hold a conference call (in English) for media, financial analysts and investors at 09.30 CEST. The report will be presented by CEO Fredrik Rågmark and CFO Joe Ryan and followed by a question-and-answer session. Shortly before the webcast, presentation slides will be available on medicover.com . To access live webcast register here . To dial in and ask questions register here 

Update on acquisition of Ferrari L. and Shareholder Letter

Oslo, 20 April 2023 – Observe Medical ASA ("the Company" or "Observe Medical") today announces it has informed Ferrari L., an Italian manufacturer of medical equipment, that the Company has decided to discontinue the process of acquiring Ferrari L. The contemplated acquisition was originally announced in a press release on 14 December 2022. This decision is the result of Observe Medical having identified a more cost-efficient manufacturer alternative, which is expected to secure high-quality volume production of the Observe Medical products. This decision will reduce the Company's future

BioStock: FDA clearance opens US market for BiBBInstruments

Medtech company BiBBInstruments recently received 510(k) clearance from the FDA for its lead product, EndoDrill GI. Now, the company expects also a new market approval in Europe  –  a CE certificate according to MDR – for all products in the EndoDrill product portfolio within 3-6 months. BioStock contacted CEO Fredrik Lindblad for a comment.Read the interview with Fredrik Lindblad at biostock.se: FDA clearance opens US market for BiBBInstruments - BioStock This is a press release from BioStock -

DecideAct moves to Microsoft Azure and joins the Microsoft ISV Success Program

The Danish software company DecideAct now migrates to the Microsoft Azure cloud platform, and its cloud-based Strategy Execution Management (SEM) platform will soon be available in the Microsoft Azure Marketplace. This is a result of DecideAct becoming a Microsoft partner and part of the Microsoft ISV Success Program for growth companies.Companies selected for Microsoft's ISV (Independent Software Vendor) Success program are considered by Microsoft to have high growth potential and will join an ecosystem with access to a wealth of knowledge, inspiration, and know-how on how to grow a SaaS

Salmon Evolution ASA: New share capital registered – Private Placement Tranche 1

20 April 2023: Reference is made to the stock exchange announcement on 19 April 2023 by Salmon Evolution ASA (“Salmon Evolution” or the “Company”) regarding the successful placement of the private placement as described therein (the “Private Placement”) and the resolution by the Board of Directors to issue 51,863,220 new shares (the “New Shares”) in Tranche 1 of the Private Placement in the Company as described therein pursuant to an authorization granted by the Company’s general meeting on 14 June 2022. The share capital increase pertaining to the issuance of the New Shares has today

Assemblin publishes its 2023 Q1 Interim Report and invites investors to a webcast on May 5, 2023

Assemblin Group AB will be publishing its 2023 Q1 Interim Report (January–March) on May 5, approximately at 07:00 CET. The Interim Report is followed up by an investor webcast at 10:00 CET.Publishing the Interim Report and briefing materialThe Interim Report as well as briefing material will be released on the company’s website at https://www.assemblin.com/investors/financial-reports/. After the webcast, a recording of the webcast will also be published there. To access the investor webcast The investor webcast (in English) is held by Assemblin´s President and CEO Mats Johansson

Elkem ASA - Invitation to first quarter 2023 results presentation

Oslo, 20 April 2023 Elkem ASA will release its report for the first quarter 2023 on Friday, 28 April at 7.00 a.m. CET. The quarterly report and presentation material will be made available at this time at www.elkem.com In connection with the quarterly report, the company will host a presentation at 8.00 a.m. CET. The event will take place in Auditoriet, Haakon Vll gate 2, Oslo. The first quarter presentation can also be viewed in a live webcast at Elkem Webcast Q1 2023 (royalcast.com)  or via www.elkem.com The

TactoTek® adds TracXon Solutions to enhance the supply of IMSE® Technology and expand the supply chain to enable sustainable 3D smart surfaces

· TactoTek and TracXon collaboration enhances the ecosystem with the addition of a cradle-to-cradle manufacturing partner · TracXon’s experience in Roll-to-Roll (R2R) printing and large-area, multi-mix assembly technology coupled with TactoTek’s innovative IMSE technology expands business opportunities for TracXon · This collaboration activates a fast and efficient ramp-up of IMSE production and serves TactoTek’s licensees in Automotive and Consumer Electronics market segments with sustainable and recycling-friendly options for smart surfacesOulu, Finland and Eindhoven, Netherlands,

Gabriella’s sought-after balcony cabins have been refurbished – "Calm and seclusion are the new luxury in maritime travel"

Vessel cabins are renovated from floor to ceiling about every 15 years. During the refurbishment, it is important to choose timeless design and sustainable solutions instead of jumping onto the latest interior design trends. When M/S Gabriella’s balcony cabins on Deck 11 were renovated, Viking Line’s architect, Johan Nordberg, let the sea views play the leading role.M/S Gabriella, which sails between Helsinki and Stockholm, has a private corridor of cabins on Deck 11, and the 22 balcony cabins there always sell out first. What is special about these cabins in the Junior Suite and Seaside

INVITATION: Finnair Q1 2023 result – Press conference / webcast and analyst webcast

Finnair will hold a Q1 2023 results press conference (in Finnish) on 27 April 2023 at 11.00 a.m. EEST at its office at Tietotie 9. It is also possible to participate in the press conference via a live webcast at https://finnairgroup.videosync.fi/2023-0427-press.    An English-language telephone conference and webcast will be held on 27 April 2023 at 1.00 p.m. EEST. To access the conference, kindly first register at https://palvelu.flik.fi/teleconference/?id=10010295. After the registration, you will be provided with phone numbers and a conference ID. We kindly suggest calling in 5

Ponsse is Finland’s best sales organisation

Ponsse and Suomen Digimarkkinointi Oy have been selected as Finland’s best sales organisations in 2022. Ponsse’s selection was based on customer closeness and the production of value for customers.The goal of the Finland’s best sales organisation competition is to promote the sales culture and increase appreciation for sales and marketing. The competition was held in cooperation with the union for professionals in sales, purchasing, and marketing (MMA) and Haaga-Helia University of Applied Sciences. The jury consisted of industry professionals, including representatives of previous years’

EasyPark Group presents new Country Director in Italy

EasyPark Group, the global leader of parking tech, has appointed Silvana Filipponi new Country Director in Italy. She takes over from Giuliano Caldo, who has assumed the role of Head of South & Central Europe at EasyPark Group. Silvana Filipponi brings with her a well-established career in the technology and digital transformation sector. She began her career at IBM before moving on to companies such as American Express, and later Visa Europe Management Services, where she held various positions before becoming Head of Brand and Product Marketing.  In 2020, she joined the

UPM Specialty Papers and Koenig & Bauer optimise digital printing for barrier papers

(UPM, Helsinki, 20 April 2023 at 12:00 EEST) – UPM Specialty Papers’ heat-sealable barrier papers have achieved excellent results in tests carried out with Koenig & Bauer's next generation of inkjet digital printing technology. This is good news for brand owners and converters interested in surpassing the limitations of conventional printing methods in order to accelerate time to market or to create more customized packaging. Testing new ground With the ability to change designs simply by updating a file, digital printing opens new possibilities for brand owners and

BioStock: Mendus steps up the clinical development in 2023

Mendus released its 2022 Annual Report this week, which refers to 2022 as a “breakthrough” year for the company. The milestones reached give Mendus the opportunity to prepare vididencel for the next phase of clinical development, reinitiate clinical development with its intratumoral primer ilixadencel, and make way for a new pipeline programme in the upcoming field of NK cell therapies. BioStock spoke with CEO Erik Manting to learn moreRead the interview with Erik Manting at biostock.se: Mendus steps up the clinical development in 2023 - BioStock 

Wyld Network's satellite IoT partners announce successful launches of additional LEO satellites on Elon Musk’s Space-X Transporter 7 rocket

Eutelsat, Lacuna Space and DEWA increase connectivity capacity for LoRaWAN satellite IoT.Wyld is thrilled to announce our satellite partners’ successful launch of new Low Earth Orbit (LEO) satellites supporting LoRaWAN for the Internet of Things. The satellites were launched on the Space-X Transporter-7 Falcon 9 rocket from Vandenberg Space Launch Complex in California on April 15th 2023.   Lacuna Space have increased their constellation from six to seven satellites. Eutelsat have now launched four satellites, ELO1,2,3 and 4. DEWA now have two LEO satellites in orbit. As capacity builds

CO2 Capsol secures financing for CapsolGo liquefaction unit through “green loan” from DNB

Oslo, Norway 20 April 2023CO2 Capsol has entered into a loan agreement with the Norwegian bank DNB forfinancing of a CapsolGo liquefaction unit. This is a “green loan” facility of 1073 400 EUR.In March 2023, CO2 Capsol announced entering into an agreement with a majorGerman energy company for the delivery of a liquefaction unit that can be usedtogether with the CapsolGo carbon capture demonstration unit. The project willbe part of the existing 12-month contract for delivery of two CapsolGodemonstration campaigns to the client, executed at one Energy-from-Waste (EfW)and one

Cereno Scientific’s Board of Directors have decided to carry out a rights issue of units of approximately SEK 110 million and intends to change marketplace to Nasdaq First North Growth Market

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE FURTHER REGISTRATION OR ANY OTHER MEASURES. The Board of Directors of Cereno Scientific AB (publ) ("Cereno Scientific" or the "Company") has, with authorization from the annual general meeting on 1 June, 2022, decided to carry out

Peptonic Medical signs global agreement with Siemens Healthineers

Peptonic Medical (PMED:SS) today announced that it has signed a non-exclusive agreement with the medical technology company Siemens Healthineers for the distribution of Peptonic’s portfolio of diagnostic products for vaginal health.The agreement with Siemens Healthineers is global and non-exclusive. It centers around Peptonic's patented diagnostic products for vaginal health. “This agreement is attractive from many aspects. We will get a very strong force in Siemens Healthineers that will help to raise awareness of the benefits of our unique and patented technology,” said Erik Sundquist,

Sectra to implement enterprise imaging SaaS in the cloud with Parkview Health in the US

Linköping, Sweden and Shelton, CT – April 20, 2023 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) will implement its enterprise imaging cloud subscription service, Sectra One Cloud, at Parkview Health in the US. This will allow the Indiana-based health system future scalability as imaging volumes grow and will ensure data security in a fully managed cloud environment.The software, operated in Microsoft Azure, offers a turnkey, fully managed SaaS solution with Sectra taking all responsibility for required infrastructure under a managed

HC Andersen Capital Events 20/04: Meet the top management in Qlife

HC Andersen Capital is hosting a digital event where you can meet and ask questions directly to the top management. It is free for all to attend.Qlife - Presentation of Q4 report and update on ongoing rights issueMeet Qlife Holding's CFO Kasper Rousøe when he presents the Q4 report and gives an update on the ongoing rights issue. The event takes place on the 20th of April – at 13:00 CET. We expect the event to last for 30 min. including questions.    Qlife Holding AB is a med-tech group that strives to revolutionize the market for clinical biomarker and virus tests. By enabling tests

There are no items matching the current filter
There are no more items matching the current filter
Back to top